IGC Pharma Inc (IGC)
0.447
+0.02
(+3.95%)
USD |
NYAM |
Apr 26, 16:00
0.48
+0.03
(+7.38%)
After-Hours: 20:00
IGC Pharma Accounts Payable (Quarterly): 0.648M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.648M |
September 30, 2023 | 0.549M |
June 30, 2023 | 0.672M |
March 31, 2023 | 0.53M |
December 31, 2022 | 0.466M |
September 30, 2022 | 0.456M |
June 30, 2022 | 0.456M |
March 31, 2022 | 0.981M |
December 31, 2021 | 0.357M |
September 30, 2021 | 0.418M |
June 30, 2021 | 0.567M |
March 31, 2021 | 0.476M |
December 31, 2020 | 0.875M |
September 30, 2020 | 0.975M |
June 30, 2020 | 1.099M |
March 31, 2020 | 0.762M |
December 31, 2019 | 0.599M |
September 30, 2019 | 0.903M |
June 30, 2019 | 0.568M |
March 31, 2019 | 0.319M |
December 31, 2018 | 0.008M |
September 30, 2018 | 0.045M |
June 30, 2018 | 1.472M |
March 31, 2018 | 0.258M |
December 31, 2017 | 0.6749M |
Date | Value |
---|---|
September 30, 2017 | 0.6131M |
June 30, 2017 | 0.4271M |
March 31, 2017 | 0.4165M |
December 31, 2016 | 0.379M |
September 30, 2016 | 0.4568M |
June 30, 2016 | 0.2592M |
March 31, 2016 | 0.3306M |
December 31, 2015 | 0.1713M |
September 30, 2015 | 0.1671M |
June 30, 2015 | 0.4258M |
March 31, 2015 | 0.1746M |
December 31, 2014 | 0.2445M |
September 30, 2014 | 0.4349M |
June 30, 2014 | 0.2971M |
March 31, 2014 | 0.1334M |
December 31, 2013 | 0.5779M |
September 30, 2013 | 0.587M |
June 30, 2013 | 0.6154M |
March 31, 2013 | 0.6007M |
December 31, 2012 | 0.2919M |
September 30, 2012 | 0.3673M |
June 30, 2012 | 0.3165M |
March 31, 2012 | 0.3371M |
December 31, 2011 | 0.9986M |
September 30, 2011 | 1.174M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.357M
Minimum
Dec 2021
1.099M
Maximum
Jun 2020
0.6504M
Average
0.568M
Median
Jun 2019
Accounts Payable (Quarterly) Benchmarks
CEL-SCI Corp | 1.144M |
AIM ImmunoTech Inc | 6.443M |
NovaBay Pharmaceuticals Inc | 1.13M |
Protalix BioTherapeutics Inc | 4.32M |
Palatin Technologies Inc | 1.594M |